Authors: Zarrouk, V Bozdogan, B Leclercq, R Garry, L Feger, C Carbon, C Fantin, B

Citation: V. Zarrouk et al., Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics (45, pg 1244, 2001), ANTIM AG CH, 45(6), 2001, pp. 1941-1941

Authors: Zarrouk, V Bozdogan, B Leclercq, R Garry, L Feger, C Carbon, C Fantin, B

Citation: V. Zarrouk et al., Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics, ANTIM AG CH, 45(4), 2001, pp. 1244-1248

Authors: Auckenthaler, R Courvalin, P Feger, C Roche, G

Citation: R. Auckenthaler et al., In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci, CL MICRO IN, 6(11), 2000, pp. 608-612

Authors: Dowzicky, M Talbot, GH Feger, C Prokocimer, P Etienne, J Leclercq, R

Citation: M. Dowzicky et al., Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid (R)) during a worldwide clinical program, DIAG MICR I, 37(1), 2000, pp. 57-62

Authors: Vouillamoz, J Entenza, JM Feger, C Glauser, MP Moreillon, P

Citation: J. Vouillamoz et al., Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistantto macrolide-lincosamide-streptogramin B antibiotics, ANTIM AG CH, 44(7), 2000, pp. 1789-1795

Authors: Feger, C

Citation: C. Feger, Imaging of breast cancer in situ, EUROCANCER 98, 1998, pp. 29-30